Piper Sandler Maintains Overweight on JPMorgan Chase, Lowers Price Target to $158
Piper Sandler analyst Jeffery Harte maintains JPMorgan Chase (NYSE:JPM) with a Overweight and lowers the price target from $170 to $158.
Raymond James Maintains Strong Buy on T-Mobile US, Raises Price Target to $160
Raymond James analyst Ric Prentiss maintains T-Mobile US (NASDAQ:TMUS) with a Strong Buy and raises the price target from $158 to $160.
Li Auto Earlier Announced Delivery of 13,024 Li ONEs in June 2022, Up 68.9% YoY; Q2 Deliveries 28,687, Up 63.2% YoY
Li Auto Inc. ("Li Auto" or the "Company") (Nasdaq: LI; HKEX: 2015), a leader in China's new energy vehicle market, today announced that the Company delivered 13,024 Li ONEs in June 2022, up 68.9% year over year. This brought the Company's second quarter deliveries to 28,687, representing a 63.2% year-over-year increase.
Piper Sandler Maintains Overweight on Citigroup, Lowers Price Target to $62
Piper Sandler analyst Jeffery Harte maintains Citigroup (NYSE:C) with a Overweight and lowers the price target from $70 to $62.
Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca’s COVID-19 Vaccine
Oxford Biomedica plc (OTC:OXBDF) signed a new three-year agreement to potentially make AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 vaccine beyond 2022. The new agreement represents…
B of A Securities Downgrades ZIM Integrated Shipping to Underperform, Lowers Price Target to $40
B of A Securities analyst Muneeba Kayani downgrades ZIM Integrated Shipping (NYSE:ZIM) from Buy to Underperform and lowers the price target from $79 to $40.
Piper Sandler Maintains Overweight on Bank of America, Lowers Price Target to $47
Piper Sandler analyst Jeffery Harte maintains Bank of America (NYSE:BAC) with a Overweight and lowers the price target from $51 to $47.
Piper Sandler Maintains Underweight on Tyson Foods, Lowers Price Target to $79
Piper Sandler analyst Michael Lavery maintains Tyson Foods (NYSE:TSN) with a Underweight and lowers the price target from $85 to $79.
Atlantic Equities Upgrades First Republic Bank to Overweight, Lowers Price Target to $188
Atlantic Equities analyst John Heagerty upgrades First Republic Bank (NYSE:FRC) from Neutral to Overweight and lowers the price target from $210 to $188.
HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $73
HC Wainwright & Co. analyst Joseph Hafling maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $60 to $73.